Observational study shows improved complication-free survival in high-risk patients, suggesting biochemical targets may enhance management strategies.
Achieving normal ALP and TB ≤0.6xULN is associated with significantly improved complication-free survival, particularly in high-risk patients. These findings highlight the potential of biochemical thresholds as a meaningful therapeutic goal in PBC management.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: